The 2018 Common Rule: Implementation Checklist

May 31, 2017 Alerts and Newsletters

As many of you know, most of the provisions of the Final Rule updating the Common Rule (“2018 Common Rule”) will go into effect, and compliance is required, on January 19, 2018. Notwithstanding some uncertainty with respect to the current Administration’s regulatory plans, as of now institutions should be taking stock of what needs to be done to bring IRBs and human research protection programs into timely compliance with the revised regulations.

To assist clients and friends in assessing high priority areas for compliance preparedness, we have attached a 2018 Common Rule Implementation Checklist here.

Also, in case you missed it, we have created a redline of HHS’s current Common Rule regulations at 45 C.F.R Part 46, Subpart A against the Final Rule. You can find and download a copy of this redline here.

Members of our Academic and Clinical Research Group (ACRG) have been busy presenting on the 2018 Common Rule and its practical implications at various conferences and webinars. Stay tuned for additional ACRG commentary on the 2018 Common Rule in the coming weeks. Be sure to follow the ACRG on our blog, Endpoints (http://clinicalresearchlawblog.com), and on Twitter (@clinicalreslaw) for additional updates.

___________________________________________________________________ 
This communication is intended for general information purposes and as a service to clients and friends of Verrill Dana, LLP. This publication, which may be considered advertising under the ethical rules of certain jurisdictions, should not be construed as legal advice or a legal opinion on any specific facts or circumstances, nor does it create attorney-client privilege.

Firm Highlights

Matter

Informed Consent Form Templates

Developed 23 different types of global research informed consent templates for a major pharmaceutical company along with detailed negotiation guidelines for compliance with applicable laws and best practices.

Matter

Research Non-Compliance Investigations

Assisted various hospital systems and research institutes with the investigation of alleged non-compliance with applicable U.S. Department of Health and Human Services (HHS) and U.S. Department of Food and Drug Administration (FDA) regulations in...

Matter

Multi-Site Global Research

Developed and negotiated site and coordinating center agreements in connection with a multi-site, international, National Institutes of Health (NIH)-funded study, and advised on regulatory issues related to the conduct of the study and subsequent...

Matter

Conflicts of Interest

Reviewed medical center’s systems, policies and procedures for identifying, assessing, and managing investigator and institutional conflicts of interest.

Publication/Podcast

Massachusetts Final Budget: MassHealth Gains Greater Authority to Negotiate Supplemental Rebates with Pharmaceutical Companies

On July 31, 2019, Governor Charlie Baker signed a $43.3 billion fiscal year 2020 budget (“ General Appropriations Act ”).  Originating from the Conference Committee’s budget, the General Appropriations Act accounts for any vetoes...

Publication/Podcast

OIG Proposes Revisions to Anti-Kickback Safe Harbor Regulations Affecting Prescription Drug Rebates

Recently, the U.S. Department of Health and Human Services (“HHS”) Office of Inspector General (“OIG”) published a  proposed rule  (“Proposed Rule”) in the  Federal Register  to amend the federal anti-kickback statute safe harbor regulations...

Publication/Podcast

Massachusetts Budget Update: Commonwealth Now Waiting on Governor Baker

On July 22, 2019, the Massachusetts House of Representatives (“House”) and Senate Conference Committee (“Conference Committee”) released the Commonwealth’s $43.1 billion fiscal year 2020 budget bill (“ H. 4000 ”). It passed the House...

Publication/Podcast

Summer is Here, But Will Your Medicare Outpatient Claims Get Paid?

CMS’  Exact Match  Requirement for Addresses Your hospital may have some corrective work to do over the next few weeks if you want to avoid delays in receiving payment for your Medicare claims for...

Publication/Podcast

U.S. Supreme Court Sides with Hospitals in Allina DSH Part C Days Decision

On June 3, 2019, the U.S. Supreme Court (“Court”) issued a 7-1 decision in  Azar v. Allina Health Services , favoring hospitals that had sued the U.S. Department of Health and Human Services (“HHS&rdquo...

Matter

European Union GDPR—Institution

Counseled a preeminent health system and academic medical center on its compliance with the European Union General Data Protection Regulation (GDPR) in relation to its clinical and research activities, including its international research studies...